New combination for patients with latent tuberculosis infection: A pilot study

Background: Latent tuberculosis infection (LTBI) is characterized by the presence of immune responses to Mycobacterium tuberculosis without clinical evidence of active TB. LTBI treatment among persons at risk for progression to active disease is an important strategy for TB control and elimination....

Full description

Bibliographic Details
Main Authors: Te-Yu Lin, Feng-Cheng Liu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Medical Sciences
Subjects:
Online Access:http://www.jmedscindmc.com/article.asp?issn=1011-4564;year=2018;volume=38;issue=6;spage=252;epage=257;aulast=Lin